Clinical Trial Update: TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [NA]

View source ↗

Summary

A completed study evaluating the pharmacokinetics of rifapentine in children during treatment of latent tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | NA | Status: COMPLETED